Rutgers Health/Robert Wood Johnson Medical School
Internal Medicine residency · New Brunswick, NJ · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Rutgers Health's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About Rutgers Healthinstitution-wide internal medicine research
Internal Medicine publications from Rutgers Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
509
works per year
55th of 129 internal medicine residency programs
+11.8%
2-year growth
46th of 129 internal medicine residency programs
17.5%
in top 10% of field (works before 2025)
87th of 120 internal medicine residency programs
38.1%
cited above world average
78th of 120 internal medicine residency programs
Works per year · * 2026 so far
Oncology · 696Pulmonary and Respiratory Medicine · 529Infectious Diseases · 359Cardiology and Cardiovascular Medicine · 300Hematology · 133
Internal Medicine research topics at Rutgers Health
Papers in the window; each links to the list on OpenAlex.
- Tuberculosis Research and Epidemiology 158
- Cancer Immunotherapy and Biomarkers 109
- Pancreatic and Hepatic Oncology Research 89
- Cancer survivorship and care 76
- CAR-T cell therapy research 74
- Prostate Cancer Diagnosis and Treatment 71
- Prostate Cancer Treatment and Research 58
- SARS-CoV-2 and COVID-19 Research 51
Most cited at Rutgers Health since 2024
All internal medicine papers there on OpenAlex
- Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton et al. · Cell · 2024 · PubMed · cited 555
- CAR T Cells and T-Cell Therapies for CancerJennifer N. Brudno et al. · JAMA · 2024 · PubMed · cited 388
- Linvoseltamab for Treatment of Relapsed/Refractory Multiple MyelomaNaresh Bumma et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 201
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular DiseaseHieronim Jakubowski et al. · International Journal of Molecular Sciences · 2025 · PubMed · cited 113
- Functional Outcomes After Localized Prostate Cancer TreatmentBashir Al Hussein Al Awamlh et al. · JAMA · 2024 · PubMed · cited 107
- Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad Ezzeddine Allaf et al. · The Lancet Oncology · 2024 · PubMed · cited 101
- Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 91
- Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerCaitlin A. McIntyre et al. · Cancer Cell · 2024 · PubMed · cited 85
- Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy CommitteePaul Turner et al. · World Allergy Organization Journal · 2024 · PubMed · cited 81